BRONCOPULMIN ORAL BRONCHODILATOR FOR HORSES Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

broncopulmin oral bronchodilator for horses

jurox pty limited - clenbuterol hydrochloride - oral powder, pre-mix - clenbuterol hydrochloride anilide/aniline active 16.0 ug/g - respiratory system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - bronchospasm | respiratory - excess mucoid secretion | respiratory cond. - constricted airways | airway constriction | constriction of airways

VENTOLIN RESPIRATOR SOLUTION 0.5% wv Singapore - englanti - HSA (Health Sciences Authority)

ventolin respirator solution 0.5% wv

glaxosmithkline pte ltd - salbutamol sulphate eqv salbutamol - solution - 0.5% w/v - salbutamol sulphate eqv salbutamol 0.5% w/v

Respiratory thermal shield Australia - englanti - Department of Health (Therapeutic Goods Administration)

respiratory thermal shield

fisher & paykel healthcare pty ltd - 61444 - respiratory thermal shield - the flow sensor shield is intended to insulate sensors for the purpose of reducing condensation.

Respiratory syncitial virus (RSV) IVDs Australia - englanti - Department of Health (Therapeutic Goods Administration)

respiratory syncitial virus (rsv) ivds

thermo fisher scientific australia pty ltd - ct746 - respiratory syncitial virus (rsv) ivds - ivds to be used in testing to provide information about infection with or exposure to viral agents

Respiratory Health Australia - englanti - Department of Health (Therapeutic Goods Administration)

respiratory health

modere australia pty ltd - marrubium vulgare, quantity: 18.75 mg (equivalent: marrubium vulgare, qty 75 mg); verbascum thapsus, quantity: 100 mg; armoracia rusticana, quantity: 40 mg (equivalent: armoracia rusticana, qty 200 mg; equivalent: volatile oil components (of armoracia rusticana), qty 300 microgram); polygala senega, quantity: 50 mg (equivalent: polygala senega, qty 500 mg); eupatorium perfoliatum, quantity: 125 mg (equivalent: eupatorium perfoliatum, qty 500 mg) - tablet, film coated - excipient ingredients: magnesium stearate; carnauba wax; croscarmellose sodium; microcrystalline cellulose; povidone; calcium hydrogen phosphate dihydrate; silicon dioxide; glucose monohydrate; dextrin; carmellose sodium; sodium citrate dihydrate; lecithin - traditionally used in western herbal medicine to maintain/support general health and wellbeing ; traditionally used in western herbal medicine to decongestant/relieve nasal congestion ; traditionally used in western herbal medicine to decrease/reduce/relieve mild bronchial irritation ; traditionally used in western herbal medicine to decrease/reduce/relieve bronchial mucous congestion ; traditionally used in native american medicine to decrease/reduce/relieve symptoms of common colds and flu ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of common colds and flu (linked indication:decrease/reduce/relieve muscle pain/ache/soreness; decrease/reduce/relieve bronchial mucous congestion; decrease/reduce/relieve chills associated with common cold; enhance/improve/promote/increase cough productivity); traditionally used in western herbal medicine to expectorant/clear respiratory tract mucous ; traditionally used in western herbal medicine to relieve symptoms of mild upper respiratory tract infections

Respiratory Gating System - Accelerator system synchronizer Australia - englanti - Department of Health (Therapeutic Goods Administration)

respiratory gating system - accelerator system synchronizer

acra regulatory services pty ltd - 47928 - accelerator system synchronizer - the device is intended to sense respiratory movement of the body surface of a patient with a respiratory sensor and acquire, display and store the respiratory information that consists of respiratory waveform and respiratory phase. the device generates the respiratory waveform signal and the gate signal that synchronizes with the respiratory information and outputs them to the external device connected for imaging diagnosis or radiation therapy. when an organ with respiratory movement is targeted by the external device synchronizing its irradiation with the respiratory information (respiratory-gated irradiation), improved accuracy of diagnostic image or radiation therapy can be attained.

Philips Respironics Porta-neb SideStream Nebulizer Compressor System Singapore - englanti - HSA (Health Sciences Authority)

philips respironics porta-neb sidestream nebulizer compressor system

philips electronics singapore pte ltd - anaesthesiology - the intended use of the porta-neb, is to provide compressed air to drive a medical nebulizer for the delivery of drugs to the patient for treatment of respiratory diseases in the home.

Philips Respironics V680 Ventilator Singapore - englanti - HSA (Health Sciences Authority)

philips respironics v680 ventilator

philips electronics singapore pte ltd - anaesthesiology - the v680 ventilator is a mechanical ventilator designed to provide invasive and non-invasive, continuous or intermittent, respiratory support in a hospital or other institutional healthcare environment. the v680 ventilator is intended for pediatric and adult patients weighing at least 5 kg (11 lb). the v680 ventilator is intended for use by qualified, trained personnel under the direction of a physician and also intended for intra-hospital transport.

Respironics InnoSpire Go Portable Mesh Nebulizer Singapore - englanti - HSA (Health Sciences Authority)

respironics innospire go portable mesh nebulizer

philips electronics singapore pte ltd - general hospital - the innospire go is a general purpose mesh nebulizer that is intended to be used to nebulize commonly prescribed liquid inhaled medications for respiratory disease. it is intended for single patient use, to deliver multiple doses. it is to be used by patients from infant to adult. it is suitable for use in the home environment, but may also be used in a hospital/clinic setting. it is not to be used by patients that are unconscious or not breathing spontaneously. the patient or the patient’s care giver is the intended operator of the device.

Respiratory Relief Australia - englanti - Department of Health (Therapeutic Goods Administration)

respiratory relief

factors group australia pty ltd - lycopersicon esculentum, quantity: 133 microgram (equivalent: lycopersicon esculentum, qty 399 microgram; equivalent: steroidal alkaloids calculated as solanine, qty 197 ng); brassica oleracea var. capitata, quantity: 368 microgram (equivalent: brassica oleracea var. capitata, qty 16.56 mg); silybum marianum, quantity: 250 microgram (equivalent: silybum marianum, qty 6.25 mg); laminaria japonica, quantity: 360 microgram (equivalent: iodine, qty 1.8 microgram); coriandrum sativum, quantity: 100 microgram; br - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; chlorophyllin-copper complex; mixed (high-alpha type) tocopherols concentrate; sodium ascorbate; potable water; maltodextrin; hypromellose; magnesium stearate; stearic acid; hydrolysed maize starch; starch sodium octenyl succinate; citric acid; silicon dioxide; microcrystalline cellulose; ascorbic acid; maltose; ascorbyl palmitate; hydroxypropyl starch; dl-alpha-tocopherol; glucose; croscarmellose sodium; ghatti gum; acacia; maize starch; glycerol; mixed (low-alpha type) tocopherols concentrate; soya oil; gelatin; sucrose - decrease/reduce/relieve symptoms of hayfever ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve mild upper respiratory tract congestion ; decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections ; decrease/reduce/relieve symptoms of sinusitis ; traditionally used in western herbal medicine to relieve symptoms of mild upper respiratory tract infections ; decrease/reduce/relieve symptoms of common cold